首页> 外文期刊>BMC Ophthalmology >Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report
【24h】

Choroidal neovascularization emerged right from the focal choroidal excavation in eyes with central serous chorioretinopathy post half-dose photodynamic therapy: a case report

机译:半剂量光动力治疗后中央性浆液性脉络膜视网膜病变眼的局灶性脉络膜开挖直接出现脉络膜新生血管:一例

获取原文
           

摘要

Focal choroidal excavation (FCE) is a common concurrent disease with central serous chorioretinopathy (CSC) and choroidal neovascularization (CNV). Photodynamic therapy (PDT) was able to cease the course of CSC with efficacy and safety. To retrospectively observed and followed up a special course in eyes with CSC and concurrent FCE treated by a half-dose of PDT. In this case report analysis, two eyes with CSC and concurrent FCE treated with half-dose PDT, were followed up with monthly retinal fundus examinations. Best corrected visual acuity (BCVA) and ophthalmic fundus examination were examined, including fundus photos, optical coherence tomography (OCT) and angiography. In Case 1, a 46-year-old female has been diagnosed as CSC and concurrent FCE. The baseline BCVA was 10/20. After a half-dose of PDT, complete resolution of SRF was achieved at one-month with stable BCVA. At 3 months, the patient complained of obvious metamorphosis. Multimodal images confirmed the existence of CNV, derived from the FCE, inside the zone of PDT irradiation. The development of CNV stopped promptly 1 month post the injection of ranibizumab. In Case 2, a 39?year-old male was diagnosed as bilateral CSC. The BCVA was 8/20 (od), and 16/20 (os). The multimodal images showed classic CSC manifestation in left eye, but atypical manifestation in right eye with subtle SRF and FCE. Post half-dose treatment, the SRF in left eye completely resolved at three-months, and the BCVA improved to 24/20. However, a lesion of CNV grew in the FCE after 1 month in right eye, with decreased BCVA, 4/20. One month post-injection of ranibizumab, obvious regression was witnessed, with improved BCVA, 6/20. The CNV proceeded to be a scar 2 months after injection. The BCVA maintained at 8/20. In this study, type II CNV was induced in two cases of CSC concurrent with FCE in 3?months post half-dose PDT. The CNV grew right from the FCE, inside the zone of PDT irradiation.
机译:局灶性脉络膜挖掘术(FCE)是一种常见的并发疾病,伴有中央浆液性脉络膜视网膜病变(CSC)和脉络膜新血管形成(CNV)。光动力疗法(PDT)能够安全有效地终止CSC的进程。回顾性观察并随访接受半剂量PDT治疗的CSC和并发FCE眼睛的特殊病程。在本病例报告分析中,对两只眼睛的CSC和同时进行的FCE进行半剂量PDT治疗,然后每月进行眼底检查。检查了最佳矫正视力(BCVA)和眼底检查,包括眼底照片,光学相干断层扫描(OCT)和血管造影。在案例1中,一名46岁的女性被诊断为CSC和并发FCE。基线BCVA为10/20。 PDT半剂量后,稳定的BCVA在一个月内达到了SRF的完全分辨率。 3个月时,患者主诉明显变态。多峰图像证实了在PDT照射区域内存在来自FCE的CNV。兰尼单抗注射后1个月,CNV的发育迅速停止。在案例2中,一名39岁的男性被诊断为双侧CSC。 BCVA为8/20(od)和16/20(os)。多峰图像显示左眼有典型的CSC表现,而右眼则具有非典型表现,并带有微妙的SRF和FCE。在半剂量治疗后,左眼的SRF在三个月时完全消失,BCVA改善到24/20。然而,右眼1个月后FCE中CNV病变增加,BCVA降低4/20。注射兰尼单抗后1个月,观察到明显的消退,BCVA改善,为6/20。注射后2个月,CNV变成了疤痕。 BCVA维持在8/20。在这项研究中,半剂量PDT后3个月内,在2例CSC合并FCE的情况下,诱发了II型CNV。 CNV在FDT的PDT照射区域内生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号